• Explore /
  • Poster
  • / Imaging response during therapy with radium-223 (Ra-223) for castration-resistant prostate cancer (CRPC) with bone metastases (BM) – A multicenter analysis.

Imaging response during therapy with radium-223 (Ra-223) for castration-resistant prostate cancer (CRPC) with bone metastases (BM) – A multicenter analysis.

Abstract Poster

Authors

Aurelius Omlin

Aurelius Gabriel Omlin

Kantonsspital St. Gallen, St. Gallen, Switzerland

Aurelius Gabriel Omlin , Gedske Daugaard , Avivit Peer , Hermann Reichegger , Avivit Neumann , Eli Rosenbaum , Marie-Claire Desax , Victoria Neiman , Peter Meidahl Petersen , Joachim Mueller , Richard Cathomas , Maya Gottfried , David Sarid , Eli Gez , Wilmosh Mermershtain , Keren Rouvinov , Jann Mortensen , Silke Gillessen , Daniel Keizman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 34, 2016 (suppl; abstr 5057)

DOI

10.1200/JCO.2016.34.15_suppl.5057

Abstract #

5057

Poster Bd #

314

Abstract Disclosures

Similar Posters

First Author: Russell Kent Pachynski

Poster

2021 ASCO Annual Meeting

Bone modifying agents in veterans with castration-resistant prostate cancer.

Bone modifying agents in veterans with castration-resistant prostate cancer.

First Author: Jordan Bauman

First Author: Bertrand F. Tombal

First Author: Megan Ann McNamara